Cargando…

Clinical outcome of advanced and metastatic renal cell carcinoma treated with targeted therapy: is there a difference between young and old patients?

BACKGROUND: To assess whether the clinical outcome of advanced and metastatic renal cell carcinoma (mRCC) treated with targeted therapy differs between young and old patients. PATIENTS AND METHODS: A total of 327 patients with advanced renal cell carcinoma and mRCC who received targeted therapy in t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Guiming, Zhu, Yao, Dong, Dahai, Gu, Weijie, Zhang, Hailiang, Sun, Lijiang, Ye, Dingwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224101/ https://www.ncbi.nlm.nih.gov/pubmed/25395863 http://dx.doi.org/10.2147/OTT.S70012

Ejemplares similares

Nutritional screening is strongly associated with overall survival in patients treated with targeted agents for metastatic renal cell carcinoma
por: Gu, Weijie, et al.
Publicado: (2015)

ADIPOQ polymorphism rs182052 is associated with clear cell renal cell carcinoma
por: Zhang, Guiming, et al.
Publicado: (2015)

Prognostic Value of Components of Body Composition in Patients Treated with Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Case Series
por: Gu, Weijie, et al.
Publicado: (2015)

Early skeletal muscle loss during target therapy is a prognostic biomarker in metastatic renal cell carcinoma patients
por: Gu, Weijie, et al.
Publicado: (2017)

Renal cell carcinoma histological subtype distribution differs by age, gender, and tumor size in coastal Chinese patients
por: Wu, Junlong, et al.
Publicado: (2017)

Oligometastatic state predicts a favorable outcome for renal cell carcinoma patients with bone metastasis under the treatment of sunitinib
por: Lu, Xiaolin, et al.
Publicado: (2016)

Impact of Estrogen on the Relationship Between Obesity and Renal Cell Carcinoma Risk in Women
por: Sun, Lijiang, et al.
Publicado: (2018)

Age-Dependent Association between Sex and Renal Cell Carcinoma Mortality: a Population-Based Analysis
por: Qu, Yuanyuan, et al.
Publicado: (2015)

Prognostic significance of the dynamic changes of systemic inflammatory response in metastatic renal cell carcinoma
por: Wang, Beihe, et al.
Publicado: (2019)

Conditional Survival in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab
por: Shao, Ning, et al.
Publicado: (2019)

A single nucleotide polymorphism in ADIPOQ predicts biochemical recurrence after radical prostatectomy in localized prostate cancer
por: Gu, Chengyuan, et al.
Publicado: (2015)

Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell Carcinoma
por: Wu, Junlong, et al.
Publicado: (2019)

Efficacy of sorafenib on metastatic renal cell carcinoma in Asian patients: Results from a multicenter study
por: Zhang, Hailiang, et al.
Publicado: (2009)

Pazopanib together with 6–8 cycles of sintilimab followed by single use of pazopanib in the second-line treatment of advanced renal cell carcinoma
por: Lu, Xiaolin, et al.
Publicado: (2021)

Prognostic Value of Lymphovascular Invasion in Node-Negative Upper Urinary Tract Urothelial Carcinoma Patients Undergoing Radical Nephroureterectomy
por: Liu, Wen, et al.
Publicado: (2019)

Serum Adiponectin Level May be an Independent Predictor of Clear Cell Renal Cell Carcinoma
por: Wang, Hongkai, et al.
Publicado: (2016)

Adverse Effect of Lymph Node Dissection in Metastatic Renal Cell Cancer Patients Treated with Cytoreductive Nephrectomy: A Contemporary Analysis of Survival
por: Cao, Dalong, et al.
Publicado: (2019)

Cancer-Associated Fibroblasts Regulate Bladder Cancer Invasion and Metabolic Phenotypes through Autophagy
por: Dong, Dahai, et al.
Publicado: (2021)

Comprehensive Analysis of BAP1 Somatic Mutation in Clear Cell Renal Cell Carcinoma to Explore Potential Mechanisms in Silico
por: Jin, Shengming, et al.
Publicado: (2018)

Beyond chemotherapy for advanced disease—the role of EGFR and PD-1 inhibitors
por: Gu, Weijie, et al.
Publicado: (2017)

A 5-lncRNA Signature Associated with Smoking Predicts the Overall Survival of Patients with Muscle-Invasive Bladder Cancer
por: Sheng, Haoyue, et al.
Publicado: (2021)

High expression of F2RL3 correlates with aggressive features and poor survival in clear cell renal cell carcinoma
por: Cao, Dalong, et al.
Publicado: (2018)

B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma
por: Qin, Xiaojian, et al.
Publicado: (2013)

Estrogen affects cell growth and IGF-1 receptor expression in renal cell carcinoma
por: Sun, Lijiang, et al.
Publicado: (2018)

Identification and validation of a ferroptosis-related signature for prediction of the prognosis and tumor microenvironment in patients with chromophobe renal cell carcinoma
por: Liu, Shuai, et al.
Publicado: (2023)

Sex Differences in the Association between Night Shift Work and the Risk of Cancers: A Meta-Analysis of 57 Articles
por: Liu, Wen, et al.
Publicado: (2018)

Response to: Comment on “Sex Differences in the Association between Night Shift Work and the Risk of Cancers: A Meta-Analysis of 57 Articles”
por: Liu, Wen, et al.
Publicado: (2019)

Tislelizumab in Asian patients with previously treated locally advanced or metastatic urothelial carcinoma
por: Ye, Dingwei, et al.
Publicado: (2020)

Metabolically Abnormal Obesity Increases the Risk of Advanced Prostate Cancer in Chinese Patients Undergoing Radical Prostatectomy
por: Liu, Wen, et al.
Publicado: (2020)

Upregulation of COL6A1 is predictive of poor prognosis in clear cell renal cell carcinoma patients
por: Wan, Fangning, et al.
Publicado: (2015)

Identification and validation of soluble carrier family expression signature for predicting poor outcome of renal cell carcinoma
por: Fangning, Wan, et al.
Publicado: (2017)

Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation
por: Gu, Cheng-Yuan, et al.
Publicado: (2021)

Decreased TCL6 expression is associated with poor prognosis in patients with clear cell renal cell carcinoma
por: Su, Hengchuan, et al.
Publicado: (2016)

Conditional disease-free survival in high-risk renal cell carcinoma treated with sunitinib
por: Shao, Ning, et al.
Publicado: (2019)

Expression of Dicer and Its Related MiRNAs in the Progression of Prostate Cancer
por: Bian, Xiaojie, et al.
Publicado: (2015)

Real-world data on the efficacy and safety of pazopanib in IMDC favorable- and intermediate-risk metastatic renal cell carcinoma: a multicenter retrospective cohort study of Chinese patients
por: Anwaier, Aihetaimujiang, et al.
Publicado: (2022)

MCT1 regulates aggressive and metabolic phenotypes in bladder cancer
por: Zhang, Guiming, et al.
Publicado: (2018)

Diagnosis of adults Xp11.2 translocation renal cell carcinoma by immunohistochemistry and FISH assays: clinicopathological data from ethnic Chinese population
por: Qu, Yuanyuan, et al.
Publicado: (2016)

Development and validation of a preoperative nomogram to predict lymph node metastasis in patients with bladder urothelial carcinoma
por: Ji, Junjie, et al.
Publicado: (2023)

Importance of HPV in Chinese Penile Cancer: A Contemporary Multicenter Study
por: Gu, Weijie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_klrmni00jujn8oaf800h63bd84